Eli Lilly CEO David Ricks Discusses Medicare Coverage of Obesity Pills
Eli Lilly Chief Executive Dave Ricks said Friday that upcoming Medicare coverage of obesity drugs could be a major catalyst…
Biotechnology and pharmaceuticals
Eli Lilly plans $3.5 billion plant in Pennsylvania for obesity drugs
Eli Lilly Chairman and CEO Dave Ricks speaks during a news conference in Houston, Sept. 23, 2025. Antranik Tavitian |…
15 drugs added to Medicare price negotiations
Boxes of the drug Trulicity, manufactured by Eli Lilly and Company, sit on a pharmacy counter in Provo, Utah, on…
Danaher Stock Fails to Rise on Strong Earnings, Leaving Us to Wonder What's Next
Danaher shares fell Wednesday as Wall Street failed to give the supplier of tools and equipment to drugmakers and hospitals…
UnitedHealth Group (UNH) Earnings in Q4 2025
UnitedHealth Group Inc. signs on the floor of the New York Stock Exchange (NYSE) in New York, U.S., on Wednesday,…
Structure Therapeutics CEO talks obesity pill and more
Ray Stevens, CEO of Structure Therapeutics Inc., during a Bloomberg Television interview at the JPMorgan Healthcare Conference in San Francisco,…
Another Alliance Between Healthcare and AI Indicates Why Pharma Stocks Could Make a Comeback
Bristol Myers Squibb and Microsoft's new partnership aimed at accelerating the early detection of lung cancer marks the latest way…
Novo Nordisk and Pfizer executives weigh in
US President Donald Trump arrives to make an announcement in the Roosevelt Room of the White House in Washington, DC,…
Keeping US biotech ahead of China could help patients with rare diseases: experts
The growth of China's biotech sector has been astonishing. Beijing is pumping money into the industry, supporting research efforts and…
Novo Nordisk shares rise after launch of anti-obesity pill Wegovy
A pharmacist displays a box of Wegovy pills at a pharmacy in Provo, Utah, on January 15, 2026. George Frey…